Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Proactive Wealth Strategies LLC

Proactive Wealth Strategies LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 917 shares of the medical equipment provider’s stock after buying an additional 30 shares during the period. Proactive Wealth Strategies LLC’s holdings in Intuitive Surgical were worth $454,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Castleark Management LLC increased its holdings in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after purchasing an additional 2,990 shares during the period. FourThought Financial Partners LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $1,158,000. Longbow Finance SA purchased a new position in Intuitive Surgical during the 4th quarter worth $4,431,000. Ewing Morris & Co. Investment Partners Ltd. acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $454,000. Finally, Whalerock Point Partners LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $209,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 215 shares of the business’s stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the transaction, the senior vice president now owns 1,768 shares in the company, valued at approximately $970,738.08. This represents a 10.84% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. Robert W. Baird dropped their target price on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Royal Bank Of Canada cut their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Piper Sandler decreased their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 23rd. Citigroup reaffirmed a “buy” rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Barclays reduced their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $588.95.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $515.09 on Tuesday. The firm has a market capitalization of $184.62 billion, a price-to-earnings ratio of 75.53, a price-to-earnings-growth ratio of 5.40 and a beta of 1.67. The company has a 50 day moving average price of $528.53 and a 200 day moving average price of $537.06. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the company posted $1.50 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.